Hawaii (State or other jurisdiction of incorporation or organization) | 6022 (Primary Standard Industrial Classification Code Number) | 99-0212597 (I.R.S. Employer Identification Number) | ||||
Large accelerated filer | ☐ | Accelerated filer | ☒ | ||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||
Emerging growth company | ☐ | ||||||||
• | Our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 26, 2025 (including those portions of our definitive proxy statement on Schedule 14A relating to our 2025 Annual Meeting of Shareholders, which was filed on March 7, 2025, incorporated by reference therein); |
• | Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on April 30, 2025; |
• | Our Current Reports on Form 8-K filed with the SEC on January 29, 2025, February 27, 2025, April 28, 2025 and June 27, 2025 (in each case, excluding Items 2.02 and 7.01 on Form 8-K and Item 9.01 related thereto); and |
• | The description of our common stock contained in our Registration Statement on Form 8-A filed with the SEC on December 12, 2002 together with any amendment or reports filed with the SEC subsequent thereto updating that description. |
• | organic growth; |
• | repaying indebtedness; |
• | repurchasing or redeeming outstanding securities; |
• | making additions to our working capital; |
• | funding future acquisitions; or |
• | for any other purpose we describe in the applicable prospectus supplement. |
• | any merger or consolidation; |
• | any sale, lease, license, exchange, pledge, transfer or other disposition of assets (in one transaction or a series of transactions) having a fair market value of $2 million or more; |
• | the issuance or transfer of any of our securities or any of our subsidiaries' securities by us or any of our subsidiaries to an interested shareholder or its affiliates having a fair market value of $2 million or more; |
• | the adoption of a plan or proposal for our liquidation or dissolution proposed by or on behalf of an interested shareholder or its affiliate; and |
• | any reclassification of securities (including any reverse stock split), recapitalization, merger or consolidation of our company with any of our subsidiaries or other transaction (whether or not involving an interested shareholder) that has the effect of increasing the proportionate share of the outstanding shares of any class of our equity or convertible securities or those of our subsidiaries owned by an interested shareholder or its affiliate. |
• | dividend rights; |
• | conversion or exchange rights; |
• | voting rights; |
• | redemption or sinking fund terms; |
• | liquidation preferences; and |
• | the number of shares constituting each such series. |
• | All outstanding depositary shares to which it relates have been redeemed. |
• | Each share of applicable preferred stock has been converted into or exchanged for common stock. |
• | The depositary has made a final distribution to the holders of the depositary shares issued under the deposit agreement upon our liquidation, dissolution or winding up. |
• | First, the trustee can enforce your rights against us if we default. There are some limitations on the extent to which the trustee acts on your behalf, which we describe below under “—Default, Remedies and Waiver of Default”; and |
• | Second, the trustee performs administrative duties for us, such as sending interest payments and notices. |
• | the title of the debt securities; |
• | whether they are senior debt securities or subordinated debt securities; |
• | any limit on the aggregate principal amount of the debt securities of the same series; |
• | the person to whom any interest on any debt security of the series will be payable, if other than the person in whose name the debt security is registered at the close of business on the regular record date; |
• | the stated maturity; |
• | the specified currency, currencies or currency units for principal and interest, if not U.S. dollars; |
• | the price at which we originally issue the debt securities, expressed as a percentage of the principal amount and the original issue date; |
• | whether the debt securities are fixed-rate debt securities, floating-rate debt securities or indexed debt securities; |
• | if the debt securities are fixed-rate debt securities, the annual rate at which the debt securities will bear interest, if any, and the interest payment dates; |
• | the regular record date for any interest payable on any interest payment date; |
• | the place or places where the principal of, premium, if any, and interest on the debt securities will be payable; |
• | the denominations in which the debt securities will be issuable, if other than denominations of $1,000 and any integral multiple of $1,000; |
• | if the debt securities are floating-rate debt securities, the interest rate benchmark; any applicable index currency or maturity, spread or spread multiplier or initial, maximum or minimum rate; the interest reset, determination, calculation and payment dates; the day count used to calculate interest payments for any period; and the calculation agent; |
• | any index or formula used to determine the amount of payments of principal of and any premium and interest on the debt securities; |
• | if the debt securities may be converted into or exchanged for our common stock or preferred stock or other securities, the terms on which the conversion or exchange may occur, including whether exchange is mandatory, at the option of the holder or at our option, the period during which exchange may occur, the initial conversion or exchange rate and the circumstances or manner in which the amount of common stock or preferred stock issuable upon conversion or exchange may be adjusted or calculated according to the market price of our common stock or preferred stock or such other securities; |
• | if the debt securities are also original issue discount debt securities, the yield to maturity; |
• | if other than the principal amount, the portion of the principal amount of the debt securities of the series which will be payable upon acceleration of the maturity of the debt securities; |
• | if applicable, the circumstances under which the debt securities may be mandatorily redeemed by us, redeemed at our option or repaid at the holder’s option before the stated maturity, including any redemption commencement date, repayment date(s), redemption price(s) and redemption period(s); |
• | if the principal amount of the debt securities which will be payable at the maturity of the debt securities will not be determinable as of any date before maturity, the amount which will be deemed to be the outstanding principal amount of the debt securities; |
• | the applicability of any provisions described below under “—Defeasance and Covenant Defeasance” ; |
• | the depositary for the debt securities, if other than The Depository Trust Company (“DTC”) and any circumstances under which the holder may request securities in non-global form; |
• | the applicability of any provisions described below under “—Default, Remedies and Waiver of Default”; |
• | any covenants applicable to the debt securities; |
• | the names and duties of any co-trustees, depositaries, authenticating agents, paying agents, transfer agents or registrars for the debt securities; |
• | the material federal income tax considerations applicable to the debt securities; and |
• | any other terms of the debt securities, which could be different from those described in this prospectus. |
• | If the successor entity in the transaction is not us, the successor entity must be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia, and must assume our obligations under the debt securities of that series and the indenture with respect to that series. |
• | Immediately after giving effect to the transaction, no default under the debt securities of that series has occurred and is continuing. For this purpose, “default under the debt securities of that series” means an event of default with respect to that series or any event that would be an event of default with respect to that series if the requirements for giving us a default notice and for our default having to continue for a specific period of time were disregarded. We describe these matters below under “—Default, Remedies and Waiver of Default.” |
• | We have delivered to the trustee an officers’ certificate and opinion of counsel, each stating that the transaction complies with the indenture. |
(i) | any of the Company’s indebtedness for borrowed or purchased money, whether or not evidenced by bonds, debentures, notes, or other written instruments, including any obligations of the Company to general creditors or trade creditors, |
(ii) | the Company’s obligations under letters of credit, |
(iii) | any of the Company’s indebtedness or other obligations with respect to commodity contracts, interest rate and currency swap agreements, cap, floor, and collar agreements, currency spot and forward contracts, and other similar agreements or arrangements designed to protect against fluctuations in currency exchange or interest rates, and |
(iv) | any guarantees, endorsements (other than by endorsement of negotiable instruments for collection in the ordinary course of business), or other similar contingent obligations in respect of obligations of others of a type described in clauses (i), (ii), and (iii), whether or not such obligation is classified as a liability on a balance sheet prepared in accordance with accounting principles generally accepted in the United States, |
• | We must deposit in trust for the benefit of all holders of those debt securities a combination of (a) money and (b) U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on those debt securities on their various due dates; |
• | (a) No event of default under the indenture may have occurred and be continuing and (b) no event of default described in the fifth bullet point under “—Default, Remedies and Waiver of Default—Events of Default” may have occurred and be continuing at any time during the 90 days following the deposit in trust; |
• | There must be a change in current federal income tax law or an Internal Revenue Service (“IRS”) ruling that lets us make the above deposit without causing the holders to be taxed on those debt securities any differently than if we did not make the deposit and just repaid those debt securities ourselves. Under current federal tax law, the deposit and our legal release from your debt security would be treated as though we took back your debt security and gave you your share of the cash and notes or bonds deposited in trust. In that event, you would recognize gain or loss on your debt security; and |
• | We must deliver to the trustee a legal opinion of our counsel confirming the tax law change described above. |
• | Any covenants that the prospectus supplement states are applicable to your debt security; and |
• | The events of default resulting from a breach of covenants, described below in the fourth, fifth and sixth bullet points under “—Default, Remedies and Waiver of Default—Events of Default.” |
• | We do not pay interest on any debt security of that series within 30 days after the due date; |
• | We do not pay the principal or any premium of any debt security of that series on the due date; |
• | We do not deposit a sinking fund payment with regard to any debt security of that series on the due date, but only if the payment is required under the applicable prospectus supplement; |
• | We remain in breach of any covenant we make in the indenture for the benefit of the relevant series for 90 days after written notice to us by the trustee or the holders of at least 25% in principal amount of the relevant series of debt securities; |
• | We file for bankruptcy or other events of bankruptcy, insolvency or reorganization relating to us occur; or |
• | If the prospectus supplement states that any additional event of default applies to the series, that event of default occurs. |
• | We do not pay interest on any debt security of that series within 30 days after the due date; |
• | We do not pay the principal or any premium of any debt security of that series on the due date; |
• | We do not deposit a sinking fund payment with regard to any debt security of that series on the due date, but only if the payment is required under the applicable prospectus supplement; |
• | We remain in breach of any covenant we make in the indenture for the benefit of the relevant series for 90 days after written notice to us by the trustee or the holders of at least 25% in principal amount of the relevant series of debt securities; |
• | We file for bankruptcy or other events of bankruptcy, insolvency or reorganization relating to us occur; or |
• | If the prospectus supplement states that any additional event of default applies to the series, that event of default occurs. |
• | The holder of your debt security must give the trustee written notice of a continuing event of default; |
• | The holders of not less than 25% in principal amount of all debt securities of your series must make a written request that the trustee take action because of the default, and they or other holders must offer to the trustee indemnity reasonably satisfactory to the trustee against the cost and other liabilities of taking that action; |
• | The trustee must not have taken action for 60 days after the above steps have been taken; and |
• | During those 60 days, the holders of a majority in principal amount of the debt securities of your series must not have given the trustee directions that are inconsistent with the written request of the holders of not less than 25% in principal amount of the debt securities of your series. |
• | changing the stated maturity for any principal or interest payment on a debt security; |
• | reduction in the principal amount or the interest rate or the premium payable upon the redemption of any debt security; |
• | reduction in the amount of principal of an original issue discount security or any other debt security payable upon acceleration of its maturity; |
• | changing the currency of any payment on a debt security; |
• | changing the place of payment on a debt security; |
• | changes that would impair a holder’s right to sue for payment of any amount due on its debt security; |
• | reduction in the percentage in principal amount of the debt securities of any series, the approval of whose holders is needed to change the applicable indenture or those debt securities; |
• | reduction in the percentage in principal amount of the debt securities of any series, the consent of whose holders is needed to waive our compliance with the applicable indenture or to waive defaults; and |
• | change in the provisions of the applicable indenture dealing with modification and waiver in any other respect, except to increase any required percentage referred to above or to add to the provisions that cannot be changed or waived without approval of the holder of each affected debt security. |
• | to evidence the succession of another person to us as obligor under the applicable indenture or to evidence the addition or release of any guarantor in accordance with the applicable indenture or any supplemental indenture; |
• | to add to our covenants for the benefit of the holders of all or any series of debt securities or to surrender any right or power conferred upon us in the applicable indenture; |
• | to add events of default for the benefit of the holders of all or any series of debt securities; |
• | to add or change any provisions of the applicable indenture to facilitate the issuance of, or to liberalize specific terms of, debt securities in bearer form, or to permit or facilitate the issuance of debt securities in uncertificated form, provided that the action will not adversely affect the interests of the holders of the debt securities of any series in any material respect; |
• | to change or eliminate any provisions of an indenture, if the change or elimination becomes effective only when there are no debt securities outstanding of any series created prior to the change or elimination that are entitled to the benefit of the changed or eliminated provision; |
• | to secure or provide for the guarantee of the debt securities; |
• | to establish the form or terms of debt securities of any series and any related coupons; |
• | to provide for the acceptance of appointment by a successor trustee or facilitate the administration of the trusts under an indenture by more than one trustee; |
• | to cure any ambiguity or correct any inconsistency in an indenture provided that the cure or correction does not adversely affect the holders of the debt securities of any series in any material respect; |
• | to supplement any of the provisions of an indenture to the extent necessary to permit or facilitate defeasance and discharge of any series of debt securities, provided that the supplement does not adversely affect the interests of the holders of the debt securities of any series in any material respect; |
• | to make provisions with respect to the conversion or exchange terms and conditions applicable to the debt securities of any series; |
• | to add to, delete from or revise the conditions, limitations or restrictions on issue, authentication and delivery of debt securities; |
• | to conform any provision in an indenture to the requirements of the Trust Indenture Act; or |
• | to make any change that does not adversely affect the legal rights under an indenture of any holder of debt securities of any series issued under that indenture. |
• | If the change affects only the debt securities of a particular series, it must be approved by the holders of a majority in principal amount of the debt securities of that series. |
• | If the change affects the debt securities of more than one series of debt securities issued under the applicable indenture, it must be approved by the holders of a majority in principal amount of each series affected by the change. |
• | if it has been surrendered for cancellation or cancelled; |
• | if we have deposited or set aside, in trust for its holder, money for its payment or redemption; |
• | if we have fully defeased it as described above under “—Defeasance and Covenant Defeasance—Full Defeasance;” |
• | if it has been exchanged for other debt securities of the same series due to mutilation, destruction, loss or theft; or |
• | if we or one of our affiliates is the owner, unless the debt security is pledged under certain circumstances described in the indenture. |
• | For an original issue discount debt security, we will use the principal amount that would be due and payable on the action date if the maturity of the debt security were accelerated to that date because of a default; |
• | For a debt security whose principal amount is not determinable, we will use any amount that we indicate in the applicable prospectus supplement for that debt security. The principal amount of a debt security may not be determinable, for example, because it is based on an index that changes from time-to-time and the principal amount is not to be determined until a later date; or |
• | For debt securities with a principal amount denominated in one or more non-U.S. dollar currencies or currency units, we will use the U.S. dollar equivalent, which we will determine. |
• | only in fully registered form; and |
• | in denominations of $1,000 and integral multiples of $1,000. |
• | on or before the applicable regular record date, in the case of a payment of interest; or |
• | on or before the 16th day before the stated maturity, or any redemption or repayment date, in the case of payment of principal or any premium. |
• | the title of the rights; |
• | the record date for determining security holders entitled to the rights distribution; |
• | the number of rights issued and the number of shares of common stock, preferred stock or other securities that may be purchased upon exercise of the rights; |
• | the identity of the rights agent; |
• | the designation and terms of the underlying securities purchasable upon exercise of the rights and the number of such underlying securities initially issuable upon exercise of the rights; |
• | if applicable, the designation and terms of the other securities with which the rights are issued and the number of such securities issued together with such rights; |
• | the date, if any, on and after which the rights will be separately transferable; |
• | if applicable, the minimum or maximum number of rights that may be exercised at any one time; |
• | the exercise price of the rights; |
• | the steps required to exercise the rights; |
• | the conditions to the completion of the offering, if any; |
• | the withdrawal, termination and cancellation rights, if any; |
• | the date on which the rights will become effective and the date on which the rights will expire; |
• | whether the rights will include oversubscription rights, so that the holder may purchase more securities if other holders do not purchase their full allotments; |
• | whether we intend to sell the shares of common stock or other securities underlying such rights that are not purchased in the offering to an underwriter or other purchaser under a contractual standby commitment or other arrangement; |
• | our ability to withdraw or terminate the rights offering prior to the expiration date of the rights; |
• | any material U.S. federal income tax consequences; or |
• | any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights. |
• | the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances the securities comprising the units may be held or transferred separately; |
• | a description of the terms of any unit agreement governing the units; |
• | a description of the provisions for the payment, settlement, transfer or exchange of the units; and |
• | whether the units will be issued in fully registered or global form. |
• | the offering price and aggregate number of warrants offered; |
• | the currency for which the warrants or rights may be purchased; |
• | if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; |
• | if applicable, the date on and after which the warrants and the related securities will be separately transferable; |
• | the securities which may be purchased by exercising the warrants (which may be common stock, preferred stock, depositary shares, debt securities or units consisting of one or more of those types of securities); |
• | the manner of exercise of the warrants, including any cashless exercise rights and, if applicable, the minimum and maximum amount of such warrants which may be exercised at any one time; |
• | the warrant agreement under which the warrants will be issued; |
• | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; |
• | the dates on which the right to exercise the warrants will commence and expire or, if the warrants are not continuously exercisable during that period, the specific date or dates on which the warrants will be exercisable; |
• | the manner in which the warrant agreement and warrants may be modified; |
• | federal income tax consequences of holding or exercising the warrants; |
• | the terms of the securities issuable upon exercise of the warrants; |
• | whether the warrants or rights will be issued in global or non-global form; |
• | any securities exchange or quotation system on which the warrants or any securities deliverable upon exercise of the warrants may be listed or quoted; and |
• | any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |
• | how it handles securities payments and notices; |
• | whether it imposes fees or charges; |
• | whether and how you can instruct it to exercise any rights to purchase or sell warrant property under a warrant contract or to exchange or convert a security for or into other property; |
• | how it would handle a request for the holders’ consent, if ever required; |
• | whether and how you can instruct it to send you securities registered in your own name so you can be a holder, if that is permitted in the future; |
• | how it would exercise rights under the securities if there were a default or other event triggering the need for holders to act to protect their interests; and |
• | if the securities are in book-entry form, how the depositary’s rules and procedures will affect these matters. |
• | DTC; |
• | a financial institution holding the securities on behalf of Euroclear; |
• | a financial institution holding the securities on behalf of Clearstream; and |
• | any other clearing system or financial institution named in the applicable prospectus supplement. |
• | An investor cannot cause the securities to be registered in his or her own name and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations we describe below; |
• | An investor will be an indirect holder and must look to his or her own bank or broker for payments on the securities and protection of his or her legal rights relating to the securities, as we describe above under “—Who Is the Legal Owner of a Registered Security?”; |
• | An investor may not be able to sell interests in the securities to some insurance companies and other institutions that are required by law to own their securities in non-book-entry form; |
• | An investor may not be able to pledge his or her interest in a global security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective; |
• | The depositary’s policies will govern payments, deliveries, transfers, exchanges, notices and other matters relating to an investor’s interest in a global security, and those policies may change from time-to-time. We, any trustee and any warrant agents and unit agents will have no responsibility for any aspect of the depositary’s policies, actions or records of ownership interests in a global security. We, any trustee and any warrant agents, rights agents and unit agents also do not supervise the depositary in any way; |
• | The depositary will require that those who purchase and sell interests in a global security within its book-entry system use immediately available funds and your broker or bank may require you to do so as well; and |
• | Financial institutions that participate in the depositary’s book-entry system and through which an investor holds its interest in the global securities, directly or indirectly, may also have their own policies affecting payments, deliveries, transfers, exchanges, notices and other matters relating to the securities, and those policies may change from time-to-time. For example, if you hold an interest in a global security through Euroclear or Clearstream, when DTC is the depositary, Euroclear or Clearstream, as applicable, will require those who purchase and sell interests in that security through them to use immediately available funds and comply with other policies and procedures, including deadlines for giving instructions as to transactions that are to be effected on a particular day. There may be more than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the policies or actions or records of ownership interests of any of those intermediaries. |
• | if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary for that global security and we do not appoint another institution to act as depositary within 60 days; |
• | if we notify the trustee, warrant agent or unit agent, as applicable, that we wish to terminate that global security; or |
• | in the case of a global security representing debt securities or warrants issued under an indenture, if an event of default has occurred with regard to these debt securities and has not been cured or waived. |
• | directly to one or more purchasers; |
• | through agents; |
• | to or through dealers or underwriters; |
• | directly to its shareholders; |
• | directly to holders of warrants exercisable for our securities upon the exercise of such warrants; |
• | directly to other purchasers; or |
• | through a combination of any of these methods of sale or any other method permitted by applicable law. |
• | at a fixed price or prices, which may be changed; |
• | at market prices prevailing at the time of sale; |
• | at prices related to prevailing market prices; |
• | at prices determined by an auction process; or |
• | at negotiated prices. |
Item 14. | Other Expenses of Issuance and Distribution. |
SEC registration fee | $45,930 | ||
Legal fees and expenses | $45,000 | ||
Accounting fees and expenses | $* | ||
Printing fees and expenses | $* | ||
Rating agency fees | $* | ||
Trustee’s and transfer agent’s fees and expenses | $* | ||
Miscellaneous | $* | ||
Total | $* | ||
* | Estimated fees and expenses are not presently known and will depend on the securities offered and the number of securities issuances. An estimate of the aggregate expenses in connection with the sale and distribution of securities being offered will be included in the applicable prospectus supplement. |
Item 15. | Indemnification of Directors and Officers |
• | the individual conducted himself or herself in good faith and the individual reasonably believed (i) in the case of conduct in the individual’s official capacity, that the individual’s conduct was in the best interests of the corporation, and (ii) in all other cases, that the individual’s conduct was at least not opposed to the best interests of the corporation; and |
• | in the case of any criminal proceeding, the individual had no reasonable cause to believe the individual’s conduct was unlawful; or |
• | the individual engaged in conduct for which broader indemnification has been made permissible or obligatory under a provision of the articles of incorporation. |
• | by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to the proceeding or who do not have a familial, financial, professional or employment relationship with the director whose indemnification is the subject of the decision being made, which relationship would reasonably be expected to influence the director’s judgment when voting on the decision being made; |
• | by special legal counsel; or |
• | by a majority vote of the shareholders. |
• | to the same extent as a director; and |
• | if the person is an officer but not a director, to such further extent as may be provided by the articles of incorporation, the bylaws, a resolution of the Board of Directors, or contract except for liability in connection with a proceeding by or in the right of the corporation other than for reasonable expenses incurred in connection with the proceeding, or liability arising out of conduct that constitutes (i) receipt by the officer of a financial benefit to which the officer is not entitled, (ii) an intentional infliction of harm on the corporation or the shareholders; or (iii) an intentional violation of criminal law. |
• | by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to such action, suit or proceeding, or |
• | if such a quorum is not obtainable, or even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion to the corporation, or |
• | by a majority vote of the shareholders. |
Item 16. | Exhibits |
1.1* | Form of Underwriting Agreement | ||
Restated Articles of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission on February 27, 2015) | |||
Statement of Cancellation of Acquired Shares, Form DC-7 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 27, 2025) | |||
Bylaws of the Registrant, as amended and restated (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 22, 2023) | |||
Form of Common Stock Certificate (incorporated herein by reference to Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Securities and Exchange Commission on February 25, 2020) | |||
4.2* | Form of Articles Amendment with respect to Preferred Stock | ||
4.3* | Form of Preferred Stock Certificate | ||
4.4* | Form of Depositary Agreement and Depositary Certificate | ||
Form of Senior Indenture for Senior Debt Securities | |||
Form of Subordinated Indenture for Subordinated Debt Securities | |||
4.7* | Form of Senior Debt Securities (included in Senior Indenture or filed at time of offering) | ||
4.8* | Form of Subordinated Debt Securities (included in Subordinated Indenture or filed at time of offering) | ||
4.9* | Form of Purchase Contract Agreement | ||
4.10* | Form of Unit Agreement and Unit Certificate | ||
4.11* | Form of Warrant Agreement and Warrant Certificate | ||
4.12* | Form of Rights Agreement and Rights Certificate | ||
Validity Opinion of Glenn K.C. Ching | |||
Validity Opinion of Manatt, Phelps & Phillips, LLP | |||
Consent of Glenn K.C. Ching (included in Exhibit 5.1) | |||
Consent of Manatt, Phelps & Phillips, LLP (included in Exhibit 5.2) | |||
Consent of Crowe LLP | |||
Power of Attorney (included on signature page to the Registration Statement) | |||
25.1** | Statement of Eligibility on Form T-1 of the Trustee under the Trust Indenture Act of 1939, as amended, under the Senior Indenture | ||
25.2** | Statement of Eligibility on Form T-1 of the Trustee under the Trust Indenture Act of 1939, as amended, under the Subordinated Indenture | ||
Filing Fee Table | |||
+ | Filed herewith. |
* | To be filed by, if necessary, subsequent to the effectiveness of this registration statement by an amendment to this registration statement or incorporated by reference in connection with the offering of securities registered hereunder or otherwise. |
** | To be filed in accordance with Section 305(b)(2) of the Trust Indenture Act of 1939, as amended, on Form 305B2 or such other permissible form, as applicable. |
Item 17. | Undertakings |
1. | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
2. | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
3. | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
4. | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |
(i) | Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
(ii) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
5. | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
6. | That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
7. | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. |
8. | The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Securities and Exchange Commission under Section 305(b)(2) of the Act. |
CENTRAL PACIFIC FINANCIAL CORP. | ||||||
By: | /s/ Arnold Martines | |||||
Arnold Martines Chairman, President and Chief Executive Officer | ||||||
Signature | Title | Date | ||||
/s/ Arnold Martines | President, Chief Executive Officer and Chairman (Principal Executive Officer) | June 30, 2025 | ||||
Arnold Martines | ||||||
/s/ Dayna N. Matsumoto | Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | June 30 2025 | ||||
Dayna N. Matsumoto | ||||||
/s/ Paul K. Yonamine | Director | June 30, 2025 | ||||
Paul K. Yonamine | ||||||
/s/ Earl E. Fry | Director | June 30, 2025 | ||||
Earl E. Fry | ||||||
/s/ Jason R. Fujimoto | Director | June 30, 2025 | ||||
Jason R. Fujimoto | ||||||
/s/ Jonathan B. Kindred | Director | June 30, 2025 | ||||
Jonathan B. Kindred | ||||||
/s/ Paul J. Kosasa | Director | June 30, 2025 | ||||
Paul J. Kosasa | ||||||
/s/ Christopher T. Lutes | Director | June 30, 2025 | ||||
Christopher T. Lutes | ||||||
/s/ Robert K.W.H. Nobriga | Director | June 30, 2025 | ||||
Robert K.W.H. Nobriga | ||||||
/s/ A. Catherine Ngo | Director | June 30, 2025 | ||||
A. Catherine Ngo | ||||||
/s/ Saedene K. Ota | Director | June 30, 2025 | ||||
Saedene K. Ota | ||||||
/s/ Crystal K. Rose | Director | June 30, 2025 | ||||
Crystal K. Rose | ||||||
/s/ Diane S.L. Paloma | Director | June 30, 2025 | ||||
Diane S.L. Paloma | ||||||